logo

RMTI

Rockwell MedicalยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

RMTI Profile

Rockwell Medical, Inc.

A commercial healthcare company that focused on life-sustaining products for blood disorders and diseases associated with the kidney

Pharmaceutical
--
01/30/1998
NASDAQ Stock Exchange
244
12-31
Common stock
30142 S. Wixom Road, Wixom, Michigan 48393
--
Rockwell Medical, Inc., was registered in Michigan in 1996 and moved to Delaware in 2019. Rockwell Pharma is a healthcare company that develops, manufactures, commercializes and distributes a portfolio of hemodialysis products to dialysis suppliers worldwide. Rockwell Pharma is a revenue generating business and the second largest supplier of acid and bicarbonate concentrates for dialysis patients in the United States. Hemodialysis is the most common form of end-stage renal disease treatment and is usually performed in independent outpatient dialysis centers, hospital outpatient centers, specialized nursing facilities, or patients' homes. Rockwell Pharma manufactures hemodialysis concentrates in compliance with current Good Manufacturing Practices (" cGMP ") regulations at its three facilities in Michigan, Texas and South Carolina, totaling approximately 175,000 square feet, and manufactures dry acid concentrates mixers at its facilities in Iowa. Rockwell Pharma utilizes its own delivery trucks and third-party carriers to deliver the majority of hemodialysis concentrate products and mixers to dialysis clinics across the United States and international dialysis clinics.